News
We provide the latest news from the world of economics and finance
(RTTNews) - Stock of MeiraGTx Holdings plc (MGTX) is rising about 5 percent on Thursday morning trading after the announcement of full-year 2025 financial results reporting narrower loss, and FDA's Breakthrough Designation for AAV2-hAQP1 treatment for Grade 2 and Grade 3 late xerostomia caused by radiotherapy for cancers of the upper aerodigestive tract.
The company's shares are currently trading at $8.04 on the Nasdaq, up 5.51 percent. The stock opened at $7.69 and has climbed as high as $8.54 so far in today's session. Over the past year, it has traded in a range of $4.55 to $9.73.
Loss declined to $114.2 million, or $1.42 a share, from $147.8 million, or $2.12 a share, last year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
© 2026 Lime Trading (CY) Ltd
Lime Trading (CY) Ltd is authorised and regulated by the Cyprus Securities and Exchange Commission in accordance with license No.281/15 issued on 25/09/2015. The "Just2Trade" trademark is owned by LimeTrading (CY) Ltd.
Registration Number: HE 341520
Address: Lime Trading (CY) Ltd
Magnum Business Center, Office 4B, Spyrou Kyprianou Avenue 78
Limassol 3076, Cyprus
Disclaimer:
All promotions, materials and information of this website may have applied conditions. Please contact the Company for further details
Trading on financial markets carries risks. The value of the investments can both increase and decrease and the investors may lose all their investment capital. In case of a leveraged product, the loss may be more than the initial capital invested. Detailed information on risks associated with trading on financial markets can be found in General Terms and Conditions for the Provision of Investment Services.
E-mail: 24_support@j2t.com
